Pancreatic Cancer Treatment Market Size Worth USD 10.55 Billion in 2032 | Emergen Research

The rising number of launch of therapies, rapid technological advancements for cancer treatment, rising investments and funding by government and non-government organizations and growing adoption of research and development activities are some of the key drivers expected to propel industry revenue growth.

The global pancreatic cancer treatment market size reached USD 2.45 Billion in 2022 and is expected to register a revenue CAGR of 15.6% during the forecast period. The steady market revenue growth can be attributed to increasing prevalence of pancreatic cancer in globe, rising number of geriatric population and increasing healthcare expenditure for pancreatic cancer treatment.

A recent market research report sheds light on the dynamics of the pancreatic cancer treatment market, highlighting both drivers and restraints influencing its growth trajectory. Pancreatic cancer, a formidable disease stemming from the uncontrolled growth of pancreatic cells, remains a significant health concern worldwide.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2872

Key Drivers Fueling Market Growth:

Technological Advancements: The pharmaceutical and biotechnology industry's relentless pursuit of innovation has led to significant strides in pancreatic cancer treatment. Modern therapies such as chemotherapy, immunotherapy, and targeted therapy have emerged, bolstering the market's revenue growth.

Increased Healthcare Expenditure: With rising cases of pancreatic cancer and a growing emphasis on research and development, healthcare expenditure for pancreatic cancer treatment has surged. This has spurred the development of novel therapies and attracted investments from biopharmaceutical companies.

Funding Initiatives: Government and non-government organizations have stepped up their efforts by providing funding and investment for pancreatic cancer treatment. Initiatives like the White House Cancer Moonshot aim to significantly reduce the cancer death rate, further driving

market growth.
Key Restraints Impeding Market Growth:
High Treatment Costs: The exorbitant cost of therapeutics for pancreatic cancer treatment poses a significant challenge to market growth. Additionally, concerns about potential side effects and product recalls by regulatory agencies further hinder market expansion.

Regulatory Hurdles: Strict regulations governing clinical trial studies for oncology drugs present another obstacle to market growth. Compliance with these regulations adds complexity and cost to the drug development process, impacting market revenue.

Market Segment Insights:
The report also provides insights into the various therapy types utilized in pancreatic cancer treatment:
Chemotherapy: Traditional chemotherapy remains a cornerstone of pancreatic cancer treatment, albeit with associated side effects.

Immunotherapy: Immunotherapy holds promise as a targeted approach to combat pancreatic cancer, leveraging the body's immune system to fight tumors.
Targeted Therapy: Precise targeting of cancer cells with minimal damage to healthy tissue is a hallmark of targeted therapy, contributing to its growing adoption in pancreatic cancer treatment.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @
https://www.emergenresearch.com/request-discount/2872

Regional Insights:

Pancreatic Cancer Treatment Asia Pacific Market
Asia Pacific revenue is expected to grow at a robust market during the forecast period attributed to increase in prevalence of pancreatic cancer, development and advancement in healthcare infrastructure and rise in number of pharmaceutical industries that aid to development of cancer therapeutics are some factors propelling growth of pancreatic cancer treatment market in this region.
Pancreatic cancer is becoming more common in China and India. For instance, according to the data published by National Institute of Health (NIH), the incidence of pancreatic cancer in India is 0.5-2.4 per 100,000 men and 0.2-1.8 per 100,000 women. Moreover, the presence of countries with high economy such as China and India that directed to encourage healthcare in this region as well as growing government regulations, major key strategic initiatives and rising research and development activities which is driving revenue growth of the market in this region.

For instance, on 22 October 2023, the Indian Institute of Technology (IIT), Madras announced the establishment of Centre of Excellence to develop and to undertake research to develop of biomarkers for early detection of pancreatic cancer. In addition, on 21 April 2021, Ono Pharmaceutical Co., Ltd. unveiled the release of its Adlumiz, a ghrelin receptor agonist for the treatment of cancer cachexia in malignant tumors of non-small cell lung cancer, gastric cancer, pancreatic cancer or colorectal cancer in Japan.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @
https://www.emergenresearch.com/select-license/2872

Major Companies and Competitive Landscape
The global pancreatic cancer treatment market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective pancreatic cancer treatment solutions.

Some major players included in the global pancreatic cancer treatment market report are:
• Eli Lilly and Company
• Pfizer Inc
• Hoffmann-La Roche Ltd
• Merck & Co., Inc.
• AstraZeneca
• Teva Pharmaceuticals USA, Inc.
• PharmaCyte Biotech, Inc.
• Novartis AG
• Amgen Inc.
• Genentech USA, Inc.

Strategic Development

On 27 September 2023, Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, declared a partnership with the Pancreatic Cancer Action Network (PanCAN), a leading nonprofit organization to fight against pancreatic cancer, in order to expand Aitia's impact and improve new drug discoveries and development for pancreatic cancers.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@
https://www.emergenresearch.com/industry-report/pancreatic-cancer-treatment-market

For the purpose of this report, Emergen Research has segmented global pancreatic cancer treatment market on the basis of Therapy Type, Cancer Type, Route of Administration, Diagnosis Type, End-Use, and region:
• Therapy Type Outlook (Revenue, USD Billion; 2019-2032)
o Chemotherapy
o Targeted Therapy
o Immunotherapy
o Hormone Therapy
o Radiation Therapy
o Others

• Cancer Type Outlook (Revenue, USD Billion; 2019-2032)
o Exocrine Pancreatic Cancer
o Endocrine Pancreatic Cancer

• Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
o Oral
o Parenteral
o Others

• Diagnosis Type Outlook (Revenue, USD Billion; 2019-2032)
o Blood Test
o Biopsy
o Imaging Tests
o Ultrasound
o Computerized tomography (CT) scans
o Magnetic resonance imaging (MRI)
o Positron emission tomography (PET) scans
o Others
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
o Clinics
o Research Institutes
o Others

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.